Artelo Biosciences, Inc. (ARTL) SEC Filings https://ir.artelobio.com/sec-filings/all-sec-filings/rss Artelo Biosciences, Inc. (ARTL) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/artelobio/files/theme/images/logo-sm.png Artelo Biosciences, Inc. Logo Equisolve Investor Relations Suite <![CDATA[424B5 - Prospectus [Rule 424(b)(5)]]]> https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001640334-26-000926/0001640334-26-000926.pdf Mon, 18 May 26 16:33:03 -0400 https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001640334-26-000926/0001640334-26-000926.pdf <![CDATA[8-K - Current report]]> https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001640334-26-000903/0001640334-26-000903.pdf Fri, 15 May 26 16:01:46 -0400 https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001640334-26-000903/0001640334-26-000903.pdf <![CDATA[SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors]]> https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001172661-26-002123/0001172661-26-002123.pdf Fri, 15 May 26 11:04:46 -0400 https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001172661-26-002123/0001172661-26-002123.pdf <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001640334-26-000869/0001640334-26-000869.pdf Thu, 14 May 26 16:10:48 -0400 https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001640334-26-000869/0001640334-26-000869.pdf <![CDATA[S-3/A - Registration statement under Securities Act of 1933]]> https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001640334-26-000867/0001640334-26-000867.pdf Thu, 14 May 26 16:01:06 -0400 https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001640334-26-000867/0001640334-26-000867.pdf <![CDATA[S-3 - Registration statement under Securities Act of 1933]]> https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001640334-26-000820/0001640334-26-000820.pdf Mon, 04 May 26 16:45:24 -0400 https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001640334-26-000820/0001640334-26-000820.pdf <![CDATA[EFFECT - Notice of Effectiveness]]> https://ir.artelobio.com/sec-filings/all-sec-filings/content/9999999995-26-001202/9999999995-26-001202.pdf Thu, 16 Apr 26 06:04:39 -0400 https://ir.artelobio.com/sec-filings/all-sec-filings/content/9999999995-26-001202/9999999995-26-001202.pdf <![CDATA[424B3 - Prospectus [Rule 424(b)(3)]]]> https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001640334-26-000761/0001640334-26-000761.pdf Thu, 16 Apr 26 08:00:43 -0400 https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001640334-26-000761/0001640334-26-000761.pdf <![CDATA[CORRESP - Correspondence]]> https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001640334-26-000693/0001640334-26-000693.pdf Wed, 13 May 26 10:54:37 -0400 https://ir.artelobio.com/sec-filings/all-sec-filings/content/0001640334-26-000693/0001640334-26-000693.pdf <![CDATA[UPLOAD - SEC-generated letter]]> https://ir.artelobio.com/sec-filings/all-sec-filings/content/0000000000-26-003674/0000000000-26-003674.pdf Wed, 13 May 26 10:54:35 -0400 https://ir.artelobio.com/sec-filings/all-sec-filings/content/0000000000-26-003674/0000000000-26-003674.pdf